Patents by Inventor Francisco Javier de ANA ARBELOA

Francisco Javier de ANA ARBELOA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220339392
    Abstract: Described herein are devices, systems and methods for monitoring the use of a nebulized medication, such as can be administered using a nebulizer. These can be used for monitoring a patient undergoing treatment for COPD and improve compliance to the recommended therapy. Monitored parameters include flow, humidity and acceleration and provide data as to the quantity and quality of nebulizer use.
    Type: Application
    Filed: July 8, 2022
    Publication date: October 27, 2022
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Michael Segal, Nathan Arian Abel, Spencer Brown, Everett Crosland, Francisco Javier de Ana Arbeloa, Thomas Goodin, Joseph Gordon, Michael Metz, Daniel James Nelson, Jae Hong Park, Sean Scanlon, Janis Paulis Skujins, Jennet Toyjanova
  • Patent number: 11406786
    Abstract: Described herein are devices, systems and methods for monitoring the use of a nebulized medication, such as can be administered using a nebulizer. These can be used for monitoring a patient undergoing treatment for COPD and improve compliance to the recommended therapy. Monitored parameters include flow, humidity and acceleration and provide data as to the quantity and quality of nebulizer use.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: August 9, 2022
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Michael Segal, Nathan Abel, Spencer Brown, Everett Crosland, Francisco Javier de Ana Arbeloa, Thomas Goodin, Joseph Gordon, Michael Metz, Daniel Nelson, Jae Hong Park, Sean Scanlon, Janis Skujins, Jennet Toyjanova
  • Publication number: 20200330719
    Abstract: Described herein are devices, systems and methods for monitoring the use of a nebulized medication, such as can be administered using a nebulizer. These can be used for monitoring a patient undergoing treatment for COPD and improve compliance to the recommended therapy. Monitored parameters include flow, humidity and acceleration and provide data as to the quantity and quality of nebulizer use.
    Type: Application
    Filed: April 22, 2019
    Publication date: October 22, 2020
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Michael SEGAL, Nathan ABEL, Spencer BROWN, Everett CROSLAND, Francisco Javier de ANA ARBELOA, Thomas GOODIN, Joseph GORDON, Michael METZ, Daniel NELSON, Jae Hong PARK, Sean SCANLON, Janis SKUJINS, Jennet TOYJANOVA